Burkitt Lymphoma Much Different Than Other B-Cell Lymphomas

Scientists at the National Cancer Institute (NCI) have uncovered the first evidence that Burkitt lymphoma (BL, sometimes called Burkitt's Lymphoma), a highly aggressive B-cell non-Hodgkin's lymphoma, is "fundamentally distinct from other types of lymphoma."

Their research, which has been published online in the journal Nature, uncovered new mutated genes and altered pathways that might give way to therapeutic treatments.

Three clinical subtypes of BL have been recognized:

  • A sporadic subtype affects all ages but is most frequent in children
  • An EBV-associated endemic subtype
  • A human immunodeficiency virus (HIV) associated subtype

In the past, BL was closely linked to the most commonly diagnosed NHL, diffuse large b-cell lymphoma (DLBCL), but recent research has provided the evidence needed to determine distinct differences between the two.

In this study, the NCI researchers concluded that the MYC oncogene was "highly mutated" in BL, and they identified several new mutations in genes that had not before been linked to Burkitt—ones that were almost never found in cases of DLBCL.

In the other direction, they compared BL biopsies to DLBCL biopsies and found mutations in the latter tumors that weren't found in Burkitt.

“Our research suggests a number of targeted therapies that might be less toxic than the high-dose chemotherapy that is typically given to patients with Burkitt lymphoma in the US," said research head Dr. Louis Staudt, "even though they have cure rates approaching 90 percent."

Source: NCI

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...